Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Gilead sciences, inc.    crawled time : 13:15    save search

Obsidian Therapeutics Appoints Maria Fardis, Ph.D., to Board of Directors
Published: 2021-10-21 (Crawled : 13:15) - biospace.com/
GILD | $67.36 0.61% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 0.15% C: -0.15%

therapeutics
Veru Announces Positive Updated Data from Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Published: 2021-09-20 (Crawled : 13:15) - biospace.com/
VERU | $1.415 11.42% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: -4.25% H: 3.62% C: -1.17%
GILD | $67.36 0.61% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.14% H: 1.4% C: 0.04%

prostate cancer phase 1 positive cancer phase 1b sabizabulin phase 2b
Veru Announces Oral Presentation of Updated Data from the Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Published: 2021-09-09 (Crawled : 13:15) - biospace.com/
VERU | $1.415 11.42% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: -1.31% H: 5.75% C: 3.73%
GILD | $67.36 0.61% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.06% C: -1.44%

presentation prostate cancer phase 1 cancer phase 1b sabizabulin phase 2b
Global $9.9 Billion Remdesivir Markets, 2021-2026 with 2020 as the Base Year - Focus on SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV
Published: 2021-08-12 (Crawled : 13:15) - prnewswire.com
GILD | $67.36 0.61% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.59% H: 1.07% C: 0.9%

covid sars-cov-2
Kite and Shoreline Biosciences Enter Into Strategic Partnership to Develop Novel Allogeneic Cell Therapies
Published: 2021-06-17 (Crawled : 13:15) - biospace.com/
GILD | $67.36 0.61% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.01% H: 0.24% C: -0.15%

partnership therapy bioscience
Gainers vs Losers
87% 13%

Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M twitter stocktwits trandingview |

AGBA | $2.355 88.4% 34M twitter stocktwits trandingview |
Finance

CZOO | $9.32 86.77% 18M twitter stocktwits trandingview |

EDBL | News | $6.75 79.52% 1.5M twitter stocktwits trandingview |

MTC | $2.28 46.15% 2.6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.14 39.56% 7.6M twitter stocktwits trandingview |
Finance

VNRX | $0.8 33.33% 2.9M twitter stocktwits trandingview |
Health Technology

MLEC | $1.865 33.21% 2.4M twitter stocktwits trandingview |
n/a

PALI | $6.37 29.21% 21M twitter stocktwits trandingview |
Manufacturing

LOCL | $3.33 27.59% 43K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.